Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine for proteinuric IgA nephropathy in children
ChiCTR-ONC-10001124Phase 4Completed
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mizoribine in IgA nephropathy (IgAN), sponsored by General Hospital of Eastern Military Command. Primary endpoints: Humoral immune indices, Blood routine test and 2 more. Started Jan 2011; status: completed.
02
Drugs
mizoribine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-ONC-10001124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-10001124.